Opportunity Information: Apply for W81XWH 09 BCRP MTA

  • The Dept. of the Army USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Breast Cancer Multi Team Award" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420 Military Medical Research and Development.
  • This funding opportunity was created on Jan 24, 2009 and posted on Jan 24, 2009.
  • Applicants must submit their applications by Jun 17, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $23,000,000.00 to eligible and selected applicants.
  • The number of recipients for this funding is limited to 3 candidate(s).
  • Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
Apply for W81XWH 09 BCRP MTA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The DoD Breast Cancer Multi Team Award (BCRP MTA) is a FY2009 funding opportunity from the Department of the Army (USAMRAA) designed to push breast cancer research forward through a tightly coordinated, highly interactive collaboration. Instead of supporting a single lab or a loosely connected consortium, this mechanism requires the creation of one integrated project carried out by three distinct teams, each led by its own Principal Investigator (PI). The intent is to build a shared, innovation-focused environment where basic and clinical research are deliberately blended, team members are cross-trained across disciplines, and breast cancer consumer advocates are built into the project as active partners rather than occasional advisors.

A central requirement is that the proposed work must revolve around a major, high-impact breast cancer research question that is either understudied or difficult to tackle because the field lacks a clear paradigm, established framework, or mature technical approach. The program is explicitly steering applicants away from narrow projects that mainly drill into isolated pathways or individual genes. Instead, it prioritizes broader questions with wide implications for breast cancer biology and patient risk management, with examples such as risk factors and tumor dormancy. Importantly, the award is not purely preclinical: the project must include clinical research, and a clinical trial is allowed and supported within early stages (Phase 0, Phase I, Phase I/II, or Phase II), making translation to patient impact a built-in expectation rather than a distant goal.

The structure of leadership and expertise is prescriptive. The three PIs, taken together, must include at least one basic scientist, one clinician, and one additional expert from a relevant discipline such as epidemiology (or another area suited to the research question). At least two separate institutions must participate, reinforcing the idea that this is meant to combine strengths and perspectives that are not typically found within one organization. Each PI is expected to bring a demonstrated track record of creativity and innovation and to contribute equally to the intellectual direction of the overall project. The application needs to reflect shared ownership: the PIs are expected to co-develop the research plan, governance and management structure, and the full proposal, with balanced effort across the three teams unless a strong justification is provided.

Consumer advocate participation is not optional and not symbolic. Each PI team must include one or more breast cancer consumer advocates who have personally been diagnosed with breast cancer and who also have substantial training and familiarity with current breast cancer research issues. These advocates are expected to be involved throughout the lifecycle of the collaboration, including shaping the initial research question, influencing study and trial design, contributing to oversight and evaluation, and participating in recruitment and other key operational elements where appropriate. This requirement signals that the program values relevance, feasibility, and accountability to patient communities as part of rigorous science.

The award places heavy emphasis on continuous collaboration, documented coordination, and hands-on cross-disciplinary training. Teams must hold in-person multi-team meetings at least twice per year, and these meetings must include all three PIs, key personnel, and the consumer advocates. Beyond that, the program expects frequent remote meetings (for example, weekly) using teleconferencing or webcast tools to share data, track progress toward aims, and resolve issues in real time. Data sharing infrastructure is also expected: applicants should plan to maintain a server or comparable resource where presentations and complete source data are accessible to all team members, reinforcing transparency and integration across institutions.

Training and immersion across disciplines is another core feature. At least two key members from each team must spend dedicated time working within another collaborating team’s lab or clinical setting to promote genuine cross-training and shared methods. This can be done through one extended visit lasting several weeks or through multiple shorter visits, but the expectation is meaningful, hands-on integration rather than superficial exchanges. Applicants also need to present a clear plan for how collaboration will be actively managed to keep three teams moving as one coordinated project, including how barriers between institutions will be addressed. Participating institutions are expected to proactively resolve intellectual property and materials-sharing issues and remove administrative obstacles that could slow cooperation.

From an application and project-management standpoint, proposals must include practical coordination tools that show how the collaboration will function day to day. This includes an organizational chart that identifies each member’s role and clarifies workflow within and between labs and clinical settings. A required Statement of Work (SOW) must lay out specific milestones, explain how the project’s aims will be staged or integrated to reach those milestones, and identify key decision points. Those decision points should be clearly tied to the overall project trajectory so reviewers can see how progress will be evaluated, how pivots will be handled, and how the teams will stay aligned.

Administratively, this opportunity was released as Funding Opportunity Number W81XWH-09-BCRP-MTA under CFDA 12.420 (Military Medical Research and Development). The instrument type is listed as a cooperative agreement/grant under the Science and Technology and other Research and Development activity category, with no cost sharing requirement. The program anticipated making 3 awards with an estimated total funding level of $23,000,000. Eligibility is described as unrestricted (open to any type of entity), subject to any additional eligibility clarifications in the full announcement. The opportunity was posted January 24, 2009, with a closing date of June 17, 2009, and an archive date of July 17, 2009. For applicants needing technical assistance, the announcement lists contact points for announcement access support and CDMRP eReceipt/help desk support.

FAQs: DoD Breast Cancer Multi Team Award (BCRP MTA) - FY2009

What is the DoD Breast Cancer Multi Team Award (BCRP MTA)?

The BCRP MTA is a FY2009 funding opportunity from the Department of the Army (USAMRAA) intended to accelerate breast cancer research through a tightly coordinated, highly interactive collaboration. It supports one integrated project carried out by three distinct teams led by three Principal Investigators (PIs), with deliberate integration of basic and clinical research and embedded participation by breast cancer consumer advocates.

What is the main purpose of this award mechanism?

The mechanism is designed to create a shared, innovation-focused environment where three teams operate as one coordinated project, cross-train across disciplines, and pursue a major, high-impact breast cancer research question that is understudied or difficult to address due to a lack of established paradigms, frameworks, or mature technical approaches.

How is this different from a typical single-lab grant or a loosely connected consortium?

Instead of funding one lab or a loosely connected group, this award requires a single integrated project executed by three separate teams. It emphasizes continuous collaboration, shared governance, documented coordination, and equal intellectual ownership by the three PIs (unless a strong justification is provided).

How many teams and PIs are required?

Three distinct teams are required, each led by its own PI. The three teams together must function as one integrated project.

What kinds of expertise must the three PIs collectively cover?

The three PIs, taken together, must include at least one basic scientist, at least one clinician, and one additional expert from a relevant discipline (for example, epidemiology or another field suited to the specific research question).

Are multiple institutions required?

Yes. At least two separate institutions must participate.

What type of research question is this program looking for?

The project must revolve around a major, high-impact breast cancer research question that is either understudied or difficult to tackle because the field lacks a clear paradigm, established framework, or mature technical approach.

What types of projects are discouraged?

The program explicitly steers applicants away from narrow projects that mainly focus on isolated pathways or individual genes.

What examples of high-impact topic areas are mentioned?

Examples provided include broad questions with implications for breast cancer biology and patient risk management, such as risk factors and tumor dormancy.

Is clinical research required?

Yes. The project must include clinical research; the award is not intended to be purely preclinical.

Are clinical trials allowed under this award?

Yes. A clinical trial is allowed and supported within early stages, including Phase 0, Phase I, Phase I/II, or Phase II.

What is the expectation around translation to patient impact?

Translation to patient impact is treated as a built-in expectation rather than a distant goal, supported by the requirement to include clinical research and the allowance for early-stage clinical trials.

What is required regarding consumer advocate involvement?

Consumer advocate participation is required and must be substantive. Each PI team must include one or more breast cancer consumer advocates who have personally been diagnosed with breast cancer and who have substantial training and familiarity with current breast cancer research issues.

What roles are consumer advocates expected to play?

Advocates are expected to be active partners throughout the project lifecycle, including shaping the initial research question, influencing study and trial design, contributing to oversight and evaluation, and participating in recruitment and other key operational elements where appropriate.

How often are in-person collaboration meetings required?

Teams must hold in-person multi-team meetings at least twice per year, and these meetings must include all three PIs, key personnel, and the consumer advocates.

Are remote meetings expected as well?

Yes. The program expects frequent remote meetings (for example, weekly) using teleconferencing or webcast tools to share data, track progress toward aims, and resolve issues in real time.

What data sharing capabilities are expected?

Applicants are expected to plan for data sharing infrastructure, such as maintaining a server or comparable resource where presentations and complete source data are accessible to all team members to support transparency and integration across institutions.

What are the cross-training requirements for team members?

At least two key members from each team must spend dedicated time working within another collaborating team’s lab or clinical setting to promote hands-on cross-training and shared methods. This can be done through one extended visit lasting several weeks or through multiple shorter visits, but it should be meaningful and immersive.

What is expected regarding management of the collaboration?

Applicants must present a clear plan for actively managing collaboration so three teams move as one coordinated project, including how barriers between institutions will be addressed. The application should reflect shared governance and management structures developed by the PIs.

What is expected from participating institutions related to intellectual property and materials sharing?

Participating institutions are expected to proactively resolve intellectual property and materials-sharing issues and remove administrative obstacles that could slow cooperation.

What coordination and project-management items must be included in the application?

Proposals must include practical coordination tools that show day-to-day functioning, including an organizational chart identifying each member’s role and clarifying workflow within and between labs and clinical settings.

Is a Statement of Work (SOW) required, and what should it include?

Yes. A required Statement of Work must lay out specific milestones, explain how aims will be staged or integrated to reach those milestones, and identify key decision points tied to the overall project trajectory so progress evaluation, pivots, and alignment are clear.

What is the funding opportunity number and CFDA listing for this program?

The Funding Opportunity Number is W81XWH-09-BCRP-MTA, and it is listed under CFDA 12.420 (Military Medical Research and Development).

What type of funding instrument is used?

The instrument type is listed as a cooperative agreement/grant under the Science and Technology and other Research and Development activity category.

Is cost sharing required?

No. The opportunity states there is no cost sharing requirement.

How many awards and how much total funding were anticipated?

The program anticipated making 3 awards with an estimated total funding level of $23,000,000.

Who is eligible to apply?

Eligibility is described as unrestricted (open to any type of entity), subject to any additional eligibility clarifications in the full announcement.

When was the opportunity posted and when was it due?

The opportunity was posted on January 24, 2009, with a closing date of June 17, 2009, and an archive date of July 17, 2009.

Where can applicants get technical help for submission or access issues?

The announcement lists contact points for announcement access support and for CDMRP eReceipt/help desk support for applicants needing technical assistance.

Browse more opportunities from the same agency: Dept. of the Army USAMRAA

Browse more opportunities from the same category: Science and Technology and other Research and Development

Next opportunity: The FY 2009 Sexual Assault Services Program Grants to Culturally Specific Programs Call for Concept Papers

Previous opportunity: DoD Breast Cancer Impact Award

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for W81XWH 09 BCRP MTA

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (W81XWH 09 BCRP MTA) also looked into and applied for these:

Funding Opportunity
Network Science Collaborative Technology Alliance (NS CTA) Apply for W911NF 08 R 0013

Funding Number: W911NF 08 R 0013
Agency: Dept of the Army Materiel Command
Category: Science and Technology and other Research and Development
Funding Amount: $252,000,000
Course, Curriculum, and Laboratory Improvement Apply for 09 529

Funding Number: 09 529
Agency: National Science Foundation
Category: Science and Technology and other Research and Development
Funding Amount: $5,000,000
DoD Peer Reviewed Medical Research Program Technology/Therapeutic Development Award Apply for W81XWH 09 PRMRP TTDA

Funding Number: W81XWH 09 PRMRP TTDA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Peer Reviewed Medical Research Program Clinical Trial Award Apply for W81XWH 09 PRMRP CTA

Funding Number: W81XWH 09 PRMRP CTA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Long Range Broad Agency Announcement (BAA) for Navy and Marine Corp Science and Technology Apply for ONRBAA09 001

Funding Number: ONRBAA09 001
Agency: Office of Naval Research
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Cooperative Ecosystem Studies Unit, Great Lakes Northern Forest CESU Apply for 09HQPA0019

Funding Number: 09HQPA0019
Agency: Geological Survey
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
CBMS BAA 07 01 Apply for CBMS BAA 07 01

Funding Number: CBMS BAA 07 01
Agency: Dept. of the Army Space Missle Defense Comman
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Space Electronics Open 5 Year Broad Agency Announcement Apply for BAA VS 06 05

Funding Number: BAA VS 06 05
Agency: Air Force Research Lab
Category: Science and Technology and other Research and Development
Funding Amount: $150,000,000
Space Components Technology Open 5 Year Broad Agency Announcement Apply for BAA VS 07 03

Funding Number: BAA VS 07 03
Agency: Air Force Research Lab
Category: Science and Technology and other Research and Development
Funding Amount: $48,000,000
DoD Peer Reviewed Medical Research Program Investigator Initiated Research Award Apply for W81XWH 09 PRMRP IIRA

Funding Number: W81XWH 09 PRMRP IIRA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Space Based Advanced Sensing and Protection Branch Open 5 Year Broad Agency Announcement Apply for BAA VS 07 07

Funding Number: BAA VS 07 07
Agency: Air Force Research Lab
Category: Science and Technology and other Research and Development
Funding Amount: $68,000,000
DoD Autism Research Program Clinical Trial Award Apply for W81XWH 09 ARP CTA

Funding Number: W81XWH 09 ARP CTA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Autism Research Program Idea Award Apply for W81XWH 09 ARP IDEA

Funding Number: W81XWH 09 ARP IDEA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Robotics Collaborative Technology Alliance (CTA) Apply for W911NF 08 R 0012

Funding Number: W911NF 08 R 0012
Agency: Dept of the Army Materiel Command
Category: Science and Technology and other Research and Development
Funding Amount: $209,700,000
Microsystems Technology Apply for DARPA BAA 08 18 PDF

Funding Number: DARPA BAA 08 18 PDF
Agency: DARPA Microsystems Technology Office
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Cognition and Neuroergonomics (CAN) Collaborative Technology Alliance (CTA) Apply for W911NF 08 R 0014

Funding Number: W911NF 08 R 0014
Agency: Dept of the Army Materiel Command
Category: Science and Technology and other Research and Development
Funding Amount: $130,000,000
DoD Breast Cancer Idea Award Apply for W81XWH 09 BCRP IDEA

Funding Number: W81XWH 09 BCRP IDEA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Breast Cancer Era of Scholar Award Apply for W81XWH 09 BCRP EOHS

Funding Number: W81XWH 09 BCRP EOHS
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DOD Neurofibromatosis Postdoctoral Traineeship Award Apply for W81XWH 09 NFRP POSTDOC

Funding Number: W81XWH 09 NFRP POSTDOC
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Breast Cancer HBCU/MI Partnership Training Award Apply for W81XWH 09 BCRP HPT

Funding Number: W81XWH 09 BCRP HPT
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 09 BCRP MTA", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.